Abstract
Natural products have been found to be useful in the treatment of several diseases across the ages. In this article, we review the use of natural products, obtained from dietary sources, as lead compounds in developing novel therapeutic agents. These compounds have shown tremendous promise in the prevention and as well as treatment of a variety of chronic ailments. In addition, to being patentable and biocompatible, these compounds are a rich source of novel scaffolds to invigorate the pipelines of the pharmaceutical industry. In this communication, we also focus on studies which show how natural products have proved useful as lead compounds in virtual screening and structure-based drug design programs. Natural dietary constituents, such as resveratrol, curcumin and caffeine as well as other compounds, are discussed to illustrate this approach.
Keywords: Caffeine, chemoprevention, curcumin, genistein, istradefylline, resveratrol, lead compounds, biocompatible, novel scaffolds, virtual screening, cancer, phytochemicals
Current Pharmaceutical Biotechnology
Title: Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design
Volume: 13 Issue: 1
Author(s): Werner J. Geldenhuys, Anupam Bishayee, Altaf S. Darvesh and Richard T. Carroll
Affiliation:
Keywords: Caffeine, chemoprevention, curcumin, genistein, istradefylline, resveratrol, lead compounds, biocompatible, novel scaffolds, virtual screening, cancer, phytochemicals
Abstract: Natural products have been found to be useful in the treatment of several diseases across the ages. In this article, we review the use of natural products, obtained from dietary sources, as lead compounds in developing novel therapeutic agents. These compounds have shown tremendous promise in the prevention and as well as treatment of a variety of chronic ailments. In addition, to being patentable and biocompatible, these compounds are a rich source of novel scaffolds to invigorate the pipelines of the pharmaceutical industry. In this communication, we also focus on studies which show how natural products have proved useful as lead compounds in virtual screening and structure-based drug design programs. Natural dietary constituents, such as resveratrol, curcumin and caffeine as well as other compounds, are discussed to illustrate this approach.
Export Options
About this article
Cite this article as:
J. Geldenhuys Werner, Bishayee Anupam, S. Darvesh Altaf and T. Carroll Richard, Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design, Current Pharmaceutical Biotechnology 2012; 13 (1) . https://dx.doi.org/10.2174/138920112798868548
DOI https://dx.doi.org/10.2174/138920112798868548 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effect of Ethyl Acetate Extract of Pomelo Mix on Systemic Exposure of Verapamil in Rabbits
Drug Metabolism Letters Update on the Pharmacological Treatment of Alzheimers Disease
Current Neuropharmacology Association of Low BMI with Aortic Stiffness in Young Healthy Individuals
Current Hypertension Reviews Organoselenium Compounds in Cancer Chemoprevention
Mini-Reviews in Medicinal Chemistry Withdrawal Notice: Electrophoresis as a Tool for Early Cancer Diagnosis
Anti-Cancer Agents in Medicinal Chemistry Sobetirome: A Selective Thyromimetic for the Treatment of Dyslipidemia
Recent Patents on Cardiovascular Drug Discovery Anaemia, Polycythaemia and Chronic Heart Failure
Current Cardiology Reviews Role of Polymorphisms in Factor V (FV Leiden), Prothrombin, Plasminogen Activator Inhibitor Type-1 (PAI-1), Methylenetetrahydrofolate Reductase (MTHFR) and Cystathionine β-Synthase (CBS) Genes as Risk Factors for Thrombophilias
Mini-Reviews in Medicinal Chemistry Recent Advances in Small Animal Cardiac Magnetic Resonance Imaging
Current Cardiology Reviews Green Tea from the Far East to the Drug Store: Focus on the Beneficial Cardiovascular Effects
Current Pharmaceutical Design Cardiovascular-Active Venom Toxins: An Overview
Current Medicinal Chemistry Role of miRNAs in Coronary Artery Disease
Current Signal Transduction Therapy A Case-Control Study Investigating the Effect of MTHFR C677T Variant on Performance of Elite Athletes
Endocrine, Metabolic & Immune Disorders - Drug Targets The Emergence of Plasma Membrane Calcium Pump as a Novel Therapeutic Target for Heart Disease
Mini-Reviews in Medicinal Chemistry Nutritional Supplements Modulating Metabolic Syndrome Risk Factors and the Prevention of Cardiovascular Disease
Current Nutrition & Food Science Inflamm-Aging, Cytokines and Aging: State of the Art, New Hypotheses on the Role of Mitochondria and New Perspectives from Systems Biology
Current Pharmaceutical Design EDITORIAL [Hot Topic: Biomarkers in Cardiovascular Disease (Guest Editor: Dimitris Tousoulis)]
Current Medicinal Chemistry Fetal Origins of Cardiovascular Disease
Current Cardiology Reviews Morphology of Atherosclerotic Plaque: Its Feature by Imaging Study
Current Pharmaceutical Design Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine